Thalassemia-an untoward situation among the pregnant women in North Bengal district, West Bengal, India
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20250617Keywords:
Pregnant women, Thalassemia carriers, Human rabiesAbstract
Background: Thalassemia, an inherited hemoglobin disorder, affects approximately 7% of the global population. In India, thalassemia prevalence ranges from 3-4%, with significant variation among different communities and regions. This study aims to document the prevalence of thalassemia carriers among pregnant women in the Dakshin Dinajpur district of West Bengal, India.
Methods: A cross-sectional study was conducted from January 2023 to November 2023. Pregnant women were screened for thalassemia at Block Primary Health Centers, and samples were analyzed at the Thalassemia Control Unit in Balurghat district hospital using High-Performance Liquid Chromatography (HPLC). Results were recorded in Thalamon software and analyzed for carrier rates and demographic correlations.
Results: Out of 12,767 pregnant women tested, 29.6% (3,790) were identified as thalassemia carriers. The highest carrier rate was in Kushm and block (45.3%), while the lowest was in Banshihari block (22.9%). Hemoglobin E(Hb-E) carriers constituted 66% of carriers, followed by hemoglobin E disease (21%) and beta thalassemia carriers (9.6%). Significant correlations were found between carrier status and caste, with beta thalassemia being more prevalent among the Scheduled Tribes.
Conclusions: The study highlights a high prevalence of thalassemia carriers among pregnant women in Dakshin Dinajpur, particularly Hb-E carriers. Genetic counselling and early screening are crucial to managing and reducing the transmission of thalassemia traits. The findings underscore the need for increased awareness and preventive measures, especially in high-risk communities. Further studies are recommended to develop strategies for reducing maternal complications and preventing carrier transmission.
Metrics
References
World Health Organization. Management of haemoglobin disorders: report of a join WHO-TIF meeting, Nicosia, Cyprus, 2007. Available at: https://iris.who.int/handle/10665/43969. Accessed 01 December 2024.
Madan N, Sharma S. Sood SK, Colah R, Bhatia HM. Frequency of beta thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16(1):16-25. DOI: https://doi.org/10.4103/0971-6866.64941
Mohanty D, Colah RB, Gorakshakar AC, Patel RZ, Master DC, Mahanta J, et al. Prevalence of beta-thalassemia and other hemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2013;4:33-42 DOI: https://doi.org/10.1007/s12687-012-0114-0
Balgir RS. Genetic epidemiology of the three predominant abnormal hemoglobins in India. J Assoc. Physicians India. 1996;44(1):25-8.
Urade BP. Sickle Cell Gene Scenario in tribal India. J Health Med Inform. 2012;3(3):114. DOI: https://doi.org/10.4172/2157-7420.1000114
Angastiniotis M, Modell B, Englezos P, Boulyjenkov VW. Prevention and control of haemoglobinopathies. Bullet World Health Organiz. 1995;73(3):375.
Baruah M, Saikia M, Baruah A. Pattern of Haemoglobinopathies and Thalasaemias in upper Assam region of North Eastern India: High performance liquid chromatography studies in 9000 patient. Indian J Pathol Microbiol. 2014;57(2):236. DOI: https://doi.org/10.4103/0377-4929.134680
Hossain MS, Raheem E, Sultana TA, Ferdous S, Nahar N, Islam S et al. Thalassemias in South Asia: clinical lessons learnt from Bangladesh. Orphanet J Rare Dis. 2017;12(1):93. DOI: https://doi.org/10.1186/s13023-017-0643-z
Dakshin Dinajpur. Wikipedia. https://en.m.wikipedia.org>wiki Accessed on January 2024.
Hemoglobin Testing System, D-10. Library of Chromatograms. BIO-RAD. 2nd edition. Available at: www.bio-rad.com/diagnostices.
A Ready Reckoner for Understanding and Interpretation of Chromatograms. HLC 273G8. TOSOH India Private Limited. The Chemistry of Innovation.
Greer JP, Arber DA, Glader B, List AF, Means RT, Paraskevas F. Wintrobe’s Clinical Hematology. 13th ed. PA, USA: Lippincott Williams & Wilkins; 2014.
Berwal V, Kyal A, Dessa D, Bhowmik J, Mondal P, Mukhopadhyay P. Pregnancy with thalassemia: challenges and outcomes. Int J Reprod Contracept Obstet Gynecol. 2018;7(4):1613-16. DOI: https://doi.org/10.18203/2320-1770.ijrcog20181365
Verma IC, Saxena R, Lall M, Bijarnia S, Sharma R. Genetic counseling and prenatal diagnosis in India-experience at Sir Ganga Ram Hospital. The Ind J Pediatr. 2003;70:293-7. DOI: https://doi.org/10.1007/BF02723582
Hanprasertpong T, Kor-anantakul O, Leetanaporn R, Suntharasaj T, Suwanrath C, Pruksanusak N, et al. (2013) Pregnancy outcomes amongst thalassemia traits. Arch Gynecol Obstet. 2013;288(5):1051-4. DOI: https://doi.org/10.1007/s00404-013-2886-9
Charoenboon C, Jatavan P, Traisrisilp K, Tongsong T. Pregnancy outcomes among women with beta-thalassemia trait. Arch Gynecol Obstet. 2016;293(4):771-4. DOI: https://doi.org/10.1007/s00404-015-3908-6
Colah R, Surve R, Wadia M, Solanki P, Mayekar P, Thomas M, Gorakshakar A, et al. Carrier screening for beta-thalassemia during pregnancy in India: a 7-year evaluation. Genet Test. 2008;12(2):181-5. DOI: https://doi.org/10.1089/gte.2007.0066